Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_assertion type Assertion NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_head.
- NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_assertion description "[Point mutations in KRAS, BRAF, and PIK3CA and ERBB2 amplification were determined in primary tumors from 63 patients with locally advanced rectal cancer scheduled for radical treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_provenance.
- NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_assertion evidence source_evidence_literature NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_provenance.
- NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_assertion SIO_000772 23226389 NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_provenance.
- NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_assertion wasDerivedFrom befree-20140225 NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_provenance.
- NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_assertion wasGeneratedBy ECO_0000203 NP626619.RAYj_igpG1coCbY2GRcHbLyDX4EkvEC3_t-jsZdKrTB9U130_provenance.